RE:RE:RTFHT and to further laugh at the bagholders on this sad MB who prefer to whine and cry like arhtur regarding Santa and meetings with incompetent ex-CEO and victim garbage like that, here is a morsel of what i have found before to help frame this "investment opportunity": this below from a basic and very good research report:
"Priority and Fast-Track products have higher first-cycle approval rates. Beyond the unmet
medical need however, increased regulatory and sponsor attention throughout the drug
development and review process may contribute to the timely identification and resolution of
issues"
"The degree of sponsor experience with FDA regulations and procedures is generally of
importance. Large US-based companies have the highest first-cycle approval rate, at
approximately twice the rate of small biotechnology companies with no prior FDA approvals."
...how do these two aspects related to TST??? IMO the market knows this and prices TST accordingly, question is is whether the market is right or wrong
odd on this bagholder MB this kind of basic knowledge is not discussed.